An emerging link between insulin resistance and inflammation

Journal of the Chinese Medical Association

Volumn 69, Issue 6, 2006, Pages 245-247

  Lin, Shih Yi ^a,b   Sheu, Wayne Huey Herng ^a,b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; ACUTE PHASE PROTEIN; ADIPONECTIN; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EARLY GROWTH RESPONSE FACTOR 1; FERRITIN; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 6; LEPTIN; METFORMIN; ORAL ANTIDIABETIC AGENT; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; BLOOD CLOTTING; BODY MASS; CONCENTRATION (PARAMETERS); CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DIET RESTRICTION; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DYSLIPIDEMIA; ERYTHROCYTE COUNT; FAT INTAKE; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; HYPOTHYROIDISM; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEUKOCYTE COUNT; MALIGNANT NEOPLASTIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; NOTE; OBESITY; OVARY POLYCYSTIC DISEASE; PARACRINE SIGNALING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTE COUNT; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

EID: 33745891476     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(09)70250-3     Document Type: Editorial

References (17)

1. Reaven GM. Insulin resistance and its consequence: type 2 diabetes mellitus and insulin resistance syndrome. In: Leroith D, Taylor SI, Olefsky JM, eds. Diabetes Mellitus: A Fundamental and Clinical Text. New York: Lippincott, Williams & Wilkins, 2004:899-916.
2. Sheu WH. The metabolic syndrome: what have we learned? J Chin Med Assoc 2004;67:597-9.
3. Lin SY, Wang YY, Liu PH, Lai WA, Sheu WH. Lower serum free thyroxine levels are associated with metabolic syndrome in a Chinese population. Metabolism 2005;54:1524-8.
4. Lin RT, Lee WJ, Jeng CY, Sheu WE, Chen YT. Metabolic syndrome and its contribution to coronary artery disease in nondiabetic subjects. J Formos Med Assoc 2004;103:317-20.
5. Tataranni PA, Ortega E. Does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? Diabetes 2005;54:917-27.
6. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111-9.
7. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548-56.
8. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004;27:813-23.
9. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005;111:1448-54.
10. Chen LK, Lin MH, Chen ZJ, Hwang SJ, Chiou ST. Association of insulin resistance and hematologic parameters: study of a middle-aged and elderly Chinese population in Taiwan. J Chin Med Assoc 2006;69:248-53.
11. Chen J, Wildman RP, Hamm LL, Munter P, Reynolds K, Whelton PK, He J. Association between inflammation and insulin resistance in U.S. nondiabetic adults. Diabetes Care 2004;27:2960-8.
12. Tseng ST, Sheu WH, Lee WJ, Ting CT, Chen YT, Jeng CY. Relationship between several surrogate estimates of insulin sensitivity in nondiabetic patients with coronary artery disease. J Formos Med Assoc 2005;104:94-100.
13. Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002;51:455-61.
14. Barbieri M, Ragno E, Benvenuti E, Zito GA, Corsi A, Ferrucci L, Paolisso G. New aspects of the insulin resistance syndrome: impact on hematological parameters. Diabetologia 2001;44: 1232-7.
15. Sheu WH, Chen YT, Lee WJ, Wang CW, Lin LY. A relationship between serum ferritin and the insulin resistance syndrome is present in nondiabetic women but not in nondiabetic men. Clin Endocrinol 2003;58:380-5.
16. Neels JG, Olefsky JM. Inflamed fat: what starts the fire? J Clin Invest 2006;116:33-5.
17. Sjoholm A, Nystrom T. Inflammation and the etiology of type 2 diabetes. Diabetes Metab Res Rev 2006;22:4-10.